Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL736885 | 0.78 | ALDH1A1 (0.36) | ALDH1A1TSHR | |
| SCHEMBL28593155 | 0.75 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL29056445 | 0.71 | TSHR (0.43) | ALDH1A1TSHR | |
| SCHEMBL1898445 | 0.71 | TSHR (0.39) | ALDH1A1TSHR | |
| SCHEMBL2248758 | 0.69 | ALDH1A1 (0.41) | ALDH1A1TSHR | |
| SCHEMBL1087681 | 0.69 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL5549372 | 0.68 | ALDH1A1 (0.40) | ALDH1A1TSHR | |
| SCHEMBL16161317 | 0.68 | ALDH1A1 (0.40) | ALDH1A1TSHR | |
| SCHEMBL2185442 | 0.68 | TSHR (0.37) | ALDH1A1TSHR | |
| SCHEMBL27448540 | 0.67 | ALDH1A1 (0.39) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3628275-B1 | HYDROGEL ARTHROPLASTY DEVICE | UNIV LELAND STANFORD JUNIOR (US) | 2023-03-01 | — | — | EP | disclosed |
| EP-3628275-A1 | HYDROGEL ARTHROPLASTY DEVICE | The Board of Trustees of the Leland Stanford Junior University (US) | 2020-04-01 | — | — | EP | disclosed |
| EP-2457539-B1 | Hydrogel arthroplasty device | UNIV LELAND STANFORD JUNIOR (US) | 2019-12-25 | — | — | EP | disclosed |
| US-20190015211-A1 | HYDROGEL ARTHROPLASTY DEVICE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2019-01-17 | — | — | US | disclosed |
| US-20160346089-A1 | HYDROGEL ARTHROPLASTY DEVICE | MYUNG DAVID (US) | 2016-12-01 | — | — | US | disclosed |
| US-9387082-B2 | Hydrogel arthroplasty device | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2016-07-12 | — | — | US | disclosed |
| US-20140172098-A1 | HYDROGEL ARTHROPLASTY DEVICE | MYUNG DAVID (US) | 2014-06-19 | — | — | US | disclosed |
| US-8679190-B2 | Hydrogel arthroplasty device | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2014-03-25 | — | — | US | disclosed |
| US-20120232657-A1 | Hydrogel Arthroplasty Device | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2012-09-13 | — | — | US | disclosed |
| US-8252878-B2 | Polymer | BIOCOMPATIBLES UK LIMITED (GB) | 2012-08-28 | — | — | US | disclosed |
| US-20090304770-A1 | POLYMER | BIOCOMPATIBLES UK LIMITED (GB) | 2009-12-10 | — | — | US | disclosed |
| US-20090088846-A1 | interpenetrating polymer network gels and an aqueous salt solution having a neutral pH for ionization and swelling the network, causing a constraining effect and an increase in elastic modulus; telechelic polymers used in orthopedic prosthetics | BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, THE | 2009-04-02 | — | — | US | disclosed |
| EP-2041196-A2 | POLYMER | Biocompatibles UK Limited (GB) | 2009-04-01 | — | — | EP | disclosed |
| WO-2008130604-A2 | HYDROGEL ARTHROPLASTY DEVICE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008006912-A2 | POLYMER | BIOCOMPATIBLES UK LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008006911-A1 | COATED IMPLANT | BIOCOMPATIBLES UK LIMITED (GB) | 2008-01-17 | — | — | WO | disclosed |
| US-7138438-B2 | Polymeric nanoparticle formulations and their use for improving the dirt pick up resistance of a coating | ROHM AND HAAS COMPANY (US) | 2006-11-21 | — | — | US | disclosed |
| US-20060217453-A1 | POLYMERIC NANOPARTICLE FORMULATIONS AND THEIR USE FOR IMPROVING THE DIRT PICK UP RESISTANCE OF A COATING | ROHM AND HAAS COMPANY | 2006-09-28 | — | — | US | disclosed |
| EP-1371718-A1 | Polymeric nanoparticle formulations and their use as fabric care additives | ROHM AND HAAS COMPANY (US) | 2003-12-17 | — | — | EP | disclosed |
| EP-1371690-A2 | Polymeric nanoparticle formulations and their use in microbe repellent coatings | ROHM AND HAAS COMPANY (US) | 2003-12-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090304770-A1 | POLYMER | MLX, BMX, PUF60 | ALDH1A1 3167/4885TSHR 2143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.